Isoniazid Monotherapy for TB Prevention

Isoniazid monotherapy is a treatment used to prevent active tuberculosis in individuals who have been exposed to M. tuberculosis. However, it is important to note that isoniazid-induced hepatitis can occur in approximately 1% of patients, with a higher risk in those over the age of 35. The risk of hepatitis is less than 0.3% in patients under 20 years old, but increases to 2-3% in individuals over 50 years old.

Aside from hepatitis, other side effects of isoniazid therapy include peripheral neuritis, which can be prevented by taking pyridoxine prophylactically. Additionally, a systemic lupus erythematosus (SLE)-like syndrome may also occur. It is important for healthcare providers to monitor patients closely for any adverse reactions while on isoniazid therapy.

When myxedema coma is suspected, it is important to administer IV corticosteroids and IV thyroid replacement simultaneously, while ruling out the possibility of adrenal insufficiency. The most suitable option is option 5, as it addresses the underlying cause and corrects life-threatening abnormalities. In this case, the patient is experiencing severe hypothyroidism and myxedema coma, which can be effectively treated with a combination of IV hydrocortisone and thyroxine. Additionally, the patient’s low blood sugar levels and elevated creatine kinase levels require management with IV fluids. While CT head and intubation may be necessary, they are not the most urgent interventions. The other options do not include the combined administration of thyroxine and hydrocortisone, which is crucial in managing the patient’s condition.

Understanding Myxoedema Coma

Myxoedema coma is a serious medical condition that is characterized by confusion and hypothermia. It is a medical emergency that requires immediate treatment. The treatment for myxoedema coma involves IV thyroid replacement, IV fluid, IV corticosteroids (until the possibility of coexisting adrenal insufficiency has been excluded), electrolyte imbalance correction, and sometimes rewarming.

Ocular Manifestations in Ankylosing Spondylitis

Patients with ankylosing spondylitis (AS) are prone to developing uveitis, an inflammation of the uvea, which can lead to vision loss if left untreated. In addition, AS can also cause blepharitis and conjunctivitis, which typically present with mild symptoms. However, if left untreated, these conditions can progress to more serious complications such as corneal melts, which are perforating corneal ulcers that can cause corneal opacities and scotomata. It is important to note that corneal melts are more commonly seen in patients with rheumatoid arthritis.

Scleritis is another ocular manifestation that can occur in patients with AS. It presents as a dusky blue discoloration of the sclera, accompanied by pain and tenderness. Unlike other ocular complications, scleritis does not typically cause photophobia or sluggish pupillary reflex.

In summary, patients with AS should be aware of the potential ocular complications associated with their condition. Regular eye exams and prompt treatment of any symptoms can help prevent vision loss and other serious complications.

Hypoadrenalism is a common complication in patients with HIV, often caused by necrotising adrenalitis related to cytomegalovirus (CMV). The weakened adaptive immune system in HIV and AIDS patients increases their vulnerability to CMV infection, which in turn increases the risk of adrenal failure.

The first step in managing hypoadrenalism is to quickly replace steroids, while also prioritizing fluid resuscitation.

There is no conclusive evidence to suggest a bacterial infection, and addressing the hypoadrenalism should resolve the hyperkalaemia.

Understanding Addisonian Crisis and Its Management

Addisonian crisis is a medical emergency that occurs when the adrenal glands suddenly stop functioning properly. This can be caused by various factors such as sepsis, surgery, adrenal haemorrhage, or steroid withdrawal. The condition is characterized by symptoms such as severe weakness, low blood pressure, dehydration, and electrolyte imbalances.

To manage Addisonian crisis, immediate medical attention is required. The first step is to administer hydrocortisone, either intravenously or intramuscularly, at a dose of 100 mg. This should be followed by the infusion of normal saline or dextrose if the patient is hypoglycaemic. Hydrocortisone should be continued every 6 hours until the patient is stable. Fludrocortisone is not required as high cortisol levels exert weak mineralocorticoid action.

After 24 hours, oral replacement therapy may begin and gradually reduced to maintenance over 3-4 days. It is important to monitor the patient’s electrolyte levels and blood pressure during this time. With prompt and appropriate management, most patients with Addisonian crisis can recover fully.

Management of acute upper gastrointestinal bleeding due to varices involves resuscitation, transfusion, and vasoactive agents like Terlipressin. Prophylactic measures include propanolol, endoscopic band ligation, and proton pump inhibitors. Common causes of upper GI bleeding include peptic ulcer disease, gastritis, and varices. In cases where endoscopy is delayed or difficult, a Sengstaken-Blakemore tube may be used.

Variceal haemorrhage is a serious condition that requires prompt and effective management. The initial treatment involves resuscitation of the patient, correction of clotting abnormalities, and administration of vasoactive agents such as terlipressin or octreotide. Prophylactic IV antibiotics are also recommended to reduce mortality in patients with liver cirrhosis. Endoscopic variceal band ligation is the preferred method for controlling bleeding, and the use of a Sengstaken-Blakemore tube or Transjugular Intrahepatic Portosystemic Shunt (TIPSS) may be necessary if bleeding cannot be controlled. However, TIPSS can lead to exacerbation of hepatic encephalopathy, which is a common complication.

To prevent variceal haemorrhage, prophylactic measures such as propranolol and endoscopic variceal band ligation (EVL) are recommended. Propranolol has been shown to reduce rebleeding and mortality compared to placebo. EVL is superior to endoscopic sclerotherapy and should be performed at two-weekly intervals until all varices have been eradicated. Proton pump inhibitor cover is given to prevent EVL-induced ulceration. NICE guidelines recommend offering endoscopic variceal band ligation for the primary prevention of bleeding for people with cirrhosis who have medium to large oesophageal varices.

Wells’ Criteria for Suspected DVT

Wells’ Criteria is a tool used to assess the likelihood of a patient having deep vein thrombosis (DVT). It assigns points based on various risk factors, with a higher score indicating a greater likelihood of DVT. In this case, the patient scores points for having active cancer, a previous DVT, collateral superficial veins, leg swelling greater than 3 cm, and entire leg swelling.

Active cancer is a known risk factor for DVT, as cancer cells can release substances that increase the risk of blood clots. A previous DVT also increases the likelihood of another occurrence. Collateral superficial veins and leg swelling are physical signs that suggest the presence of a blood clot. If the entire leg is swollen, it may indicate a more severe case of DVT.

Wells’ Criteria is important for healthcare professionals to accurately diagnose and manage DVT. By identifying patients at higher risk, appropriate interventions can be taken to prevent complications such as pulmonary embolism. It is recommended to use this tool in conjunction with other diagnostic tests, such as ultrasound, to confirm or rule out DVT.

Due to cisplatin chemotherapy, this patient is experiencing acute kidney injury and requires adjustments to their pain management. As they are currently taking regular, long-acting MST, the most suitable alternative would be a fentanyl patch.

While oxycodone can be used for moderate renal failure, it should only be used for breakthrough pain relief and modified release preparations should be avoided. Diamorphine and tramadol are not recommended for patients with renal failure. Pregabalin can be administered at a reduced dose, but it would not be the first choice for substituting MST.

Alfentanil and methadone are safe to use even in severe renal impairment and can be administered subcutaneously. If the patient’s pain is unstable and requires dose titration, alfentanil would be a suitable option.

Palliative care prescribing for pain is guided by NICE and SIGN guidelines. NICE recommends starting with regular oral modified-release or immediate-release morphine, with immediate-release morphine for breakthrough pain. Laxatives should be prescribed for all patients initiating strong opioids, and antiemetics should be offered if nausea persists. Drowsiness is usually transient, but if it persists, the dose should be adjusted. SIGN advises that the breakthrough dose of morphine is one-sixth the daily dose, and all patients receiving opioids should be prescribed a laxative. Opioids should be used with caution in patients with chronic kidney disease, and oxycodone is preferred to morphine in patients with mild-moderate renal impairment. Metastatic bone pain may respond to strong opioids, bisphosphonates, or radiotherapy, and all patients should be considered for referral to a clinical oncologist for further treatment. When increasing the dose of opioids, the next dose should be increased by 30-50%. Conversion factors between opioids are also provided. Opioid side-effects include nausea, drowsiness, and constipation, which are usually transient but may persist. Denosumab may be used to treat metastatic bone pain in addition to strong opioids, bisphosphonates, and radiotherapy.

Treatment options for diabetic gastroparesis

Gastroparesis is a common complication of diabetes mellitus, affecting gastric motility in approximately 10% of patients. Endoscopy is the first step in investigating the condition, ruling out anatomical lesions such as pyloric stenosis. Gastric emptying scans using solid-phase meals are usually necessary to confirm the diagnosis.

Improving diabetic control can be beneficial, but prokinetic drugs such as domperidone are the initial intervention of choice. Metoclopramide is no longer recommended due to long-term neurological side effects. Patients should also be encouraged to eat smaller, more frequent meals with a lower potential residual solid component to minimize solid food retention in the stomach.

Nifedipine has no role in the treatment of diabetic gastroparesis, but it may be used to treat oesophageal spasm in achalasia. High-fibre diets may exacerbate symptoms by leaving significant residual solid material in the stomach. Gastric pacemakers are considered a research intervention for patients with gastroparesis resistant to other treatments.

Treatment Options for Obstructive Sleep Apnoea

Obstructive sleep apnoea (OSA) is a common sleep disorder that can lead to serious health complications if left untreated. The following are treatment options for OSA:

1. Overnight continuous positive airway pressure (CPAP): This is the first-line treatment for moderate to severe OSA. CPAP has been shown to be effective in reducing OSA symptoms, but it does not prevent cardiovascular mortality associated with OSA.

2. Intra-oral device to prevent snoring: This may be useful for mild OSA, but not in cases of daytime sleepiness.

3. Long-term oxygen therapy: This can be used as an adjunct to CPAP therapy or in cases where patients are unable to adhere to CPAP. However, it should not be offered as first-line in preference to CPAP.

4. Modafinil: This is a daytime stimulant used in the treatment of narcolepsy. It is not used in the management of OSA, but has been shown to have beneficial effects in use with CPAP.

5. Nocturnal lorazepam: This is an inappropriate treatment option for OSA as benzodiazepines are contraindicated and can lead to respiratory failure.

Patients with OSA should also alter their lifestyle appropriately, with weight loss and alcohol and smoking cessation as first-line treatment. Long-term oxygen therapy has not been shown to have any long-term benefit in OSA patients.

For the majority of neck lumps, high-resolution ultrasound scanning is the recommended initial imaging investigation. This is because most neck lesions are specific to a particular site, and once the location of the lesion has been identified, specific ultrasound characteristics can be utilized to determine the diagnosis.

Understanding Thyrotoxicosis: Causes and Investigations

Thyrotoxicosis is a condition characterized by an overactive thyroid gland, resulting in an excess of thyroid hormones in the body. Graves’ disease is the most common cause, accounting for 50-60% of cases. Other causes include toxic nodular goitre, subacute thyroiditis, post-partum thyroiditis, Hashimoto’s thyroiditis, amiodarone therapy, and contrast administration. Elderly patients with pre-existing thyroid disease are also at risk.

To diagnose thyrotoxicosis, doctors typically look for a decrease in thyroid-stimulating hormone (TSH) levels and an increase in T4 and T3 levels. Thyroid autoantibodies may also be present. Isotope scanning may be used to investigate further. It is important to note that many causes of hypothyroidism may have an initial thyrotoxic phase, highlighting the complexity of thyroid dysfunction. Patients with existing thyrotoxicosis should avoid iodinated contrast medium, as it can result in hyperthyroidism developing over several weeks.